title: Case report: development of Hodgkin's disease in patient receiving long-term administration of dacarbazine and interleukin-2 for metastatic melanoma.
authors.affiliation: Division of Hematology and Oncology, Wayne State University, School of Medicine, Detroit, Mich.
authors.forename: L E
authors.initials: LE
authors.lastname: Flaherty
authors.forename: R
authors.initials: R
authors.lastname: Schwert
authors.forename: B G
authors.initials: BG
authors.lastname: Redman
mesh_terms: D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000139:chemically induced*; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary; D008875:Middle Aged
chemical_list: D007376:Interleukin-2; D003606:Dacarbazine